On the other hand, some markers (i.e. IL-5, IL-7, IL-17A, CXCL8 and VEGF) were increased in critical COVID-19 patients only and not in MAS (Fig. 1a and Suppl. This evidence concerns the gene CXCL8 and macrophage activation syndrome.